Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jvir.2018.12.017 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Revascularization techniques for complete portomesenteric venous occlusion in patients undergoing pancreatic resection.
HPB (Oxford)
November 2024
Section of Hepatobiliary & Pancreatic Surgery, Department of Surgery, Stanford University Hospital, Stanford, CA, USA. Electronic address:
Introduction: Pancreatic pathologies causing portomesenteric occlusion complicate extirpative pancreatic resection due to portomesenteric hypertension and collateral venous drainage.
Methods: Patients with portomesenteric occlusion undergoing pancreatectomy were identified between 2007 and 2020 at Stanford University Hospital. Demographic and clinical data, technique and perioperative factors, and post-operative outcomes were analyzed.
Makeshift Shunts in Extrahepatic Portal Vein Obstruction in Pediatric Population.
J Indian Assoc Pediatr Surg
March 2024
Department of Radiodiagnosis, All India Institute of Medical Sciences, New Delhi, India.
Background And Objectives: More than 20% of patients with extrahepatic portal vein obstruction (EHPVO) may be deemed as nonshuntable due to lack of a suitable vein. The role of "makeshift shunts" or "lesser shunts" assumes importance in such cases. In this report, the authors have shared their experience with the makeshift shunts in the management of portal hypertension in children with emphasis upon anatomic considerations, resolution of symptoms, outcomes after surgery, and shunt patency.
View Article and Find Full Text PDFTransjugular Intrahepatic Portosystemic Shunt (TIPS) Extension for Transhepatic Mesocaval Shunt Creation: A Case Series for Treating Refractory Upper Gastrointestinal Bleeding in Patients with Chronic Portal Vein Thrombosis.
Indian J Radiol Imaging
April 2024
Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
Transjugular intrahepatic portosystemic shunt (TIPS) is known to benefit patients with decompensated liver disease by alleviating portal pressure. However, TIPS creation is technically difficult and challenging to perform in patients with chronic portal vein thrombosis (PVT) (4,5). Multiple endovascular techniques for portal vein recanalization with or without creating portosystemic shunt are available to decompress and alleviate portal hypertension in patients with PVT.
View Article and Find Full Text PDFOutcomes of Portosystemic Shunts in Children with and without Liver Transplantation.
Pediatr Gastroenterol Hepatol Nutr
January 2024
Department of Pediatrics, Transplant Institute, Medstar Georgetown University Hospital, Washington, D.C., USA.
Purpose: Limited data exist regarding outcome and morbidity associated with portosystemic shunts in the pediatric transplant population. Our study assesses the outcomes of pediatric patients who underwent a portosystemic shunt procedure, both with and without liver transplantation (LT).
Methods: This study retrospectively reviewed the medical records of pediatric patients aged 0-19 years who underwent shunt placement between 2003 and 2017 at a tertiary care center.
Percutaneous mesocaval shunt creation for portal thrombosis in a patient with a JAK2V617F mutation.
Thromb Res
February 2024
Division of Interventional Radiology, Russell H. Morgan Department of Radiology and Radiological Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Electronic address:
Myeloproliferative neoplasms (MPN) are the most common cause of noncirrhotic, nontumoral portal vein thrombosis (PVT). Over 90 % of MPN patients with PVT carry the JAK2V617F mutation. Compared to other etiologies of PVT, patients with JAK2V617F MPNs are at increased risk of developing significant portal hypertension.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!